Physician profile
Kelli Baker
NPI 1649568171
$2,074.67
in general payments reported to CMS, 2019-2025
25 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $631 · 2023: $764 · 2024: $211 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.13 | 2021-2023 | |
| Lilly USA, LLC | $309.97 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Abbott Laboratories | $289.33 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $287.90 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Inspire Medical Systems, INC. | $172.63 | 2024-2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $75.13 | 2021-2022 | |
| Dexcom, INC. | $73.40 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $72.75 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $63.77 | 2022 | |
| Pfizer INC. | $52.93 | 2023-2025 | |
| Mylan Specialty L.P. | $43.72 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.39 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $33.42 | 2021 | |
| Dynavax Technologies Corporation | $31.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.90 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.87 | 2021 | |
| Impulse Dynamics (USA) INC. | $23.49 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $20.29 | 2023 | Fasenra |
| Horizon Therapeutics Plc | $19.39 | 2023 | Krystexxa |
| Vbi Vaccine (Delaware) INC. | $17.90 | 2022 | |
| Astellas Pharma US INC | $16.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.69 | 2023 | |
| Edwards Lifesciences Corporation | $15.68 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $14.57 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.